Scholars Central

EditorialPublished 2016

Simeprevir, Sofosbuvir and Ribavirin as First Line Therapy of HCV Infection, is it Justifiable Enough Basing on Safety and Efficacy?

Authors: Mina T. Kelleni

More from this journal

The newest in General Medicine: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGeneral Medicine: Open Access
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Mina T. Kelleni”